Article
The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology - 1 Dec 2013
Disertori Marcello, Quintarelli Silvia, Mazzola Silvia, Favalli Valentina, Narula Nupoor, Arbustini Eloisa
Abstract excerpt
Left ventricular ejection fraction (LVEF) ≤35% is a major determinant for implantable cardioverter-defibrillator (ICD) therapy for primary prevention of sudden death (SD) in patients with non-ischaemic dilated cardiomyopathy (DCM). However, as a risk marker for SD, low LVEF has limited sensibilit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.